Who invested in Blueprint Medicines?
3 investors are on record as having backed Blueprint Medicines — Develops therapies for allergy, oncology, and mast cell diseases, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.
Blueprint Medicines investors
Foresite Capital Management, LLCMulti-stage healthcare and life sciences investor using data science to back companies at…their site
Ra Capital Management, LPFunds and scales companies across healthcare and planetary health, pairing scientific…their site
1 more investors on record for Blueprint Medicines.
The first two are open to everyone. A free account opens the rest — the fund, the round, the amount and where each number came from. No card, no demo call.
No round dates are on record for Blueprint Medicines. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Blueprint Medicines are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.